DEADLINE ALERT for APYX, VRCA, APPS and TDOC: the law

LOS ANGELES, June 10, 2022 (GLOBE NEWSWIRE) — The law firm of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly traded companies. Investors have until the deadlines listed below to file as lead plaintiff.

Investors experiencing losses on their investments are encouraged to contact the law offices of Frank R. Cruz to discuss their legal rights in these class action lawsuits at 310-914-5007 or by email at fcruz@frankcruzlaw.com.

Apyx Medical Corporation (NASDAQ:APYX)
Course period: May 12, 2021 – March 11, 2022
Lead Applicant Deadline: August 5, 2022

The Complaint filed in this Class Action alleges that throughout the Class Period, the Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the business, operations and societal prospects. Specifically, the defendants failed to disclose to investors: (1) that a significant number of Apyx’s Advanced Energy products were used for non-compliant indications; (2) that these off-label uses have resulted in an increase in the number of medical device reports filed by Apyx of serious adverse events; (3) that, as a result, the Company was reasonably likely to be subject to regulatory scrutiny; (4) that as a result of the foregoing, the Company’s financial results would be adversely affected; and (5) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)
Course period: May 28, 2021 – May 24, 2022
Lead Applicant Deadline: August 5, 2022

The Complaint filed in this Class Action alleges that throughout the Class Period, the Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the business, operations and societal prospects. Specifically, defendants failed to disclose to investors: (1) that there were manufacturing defects in the facility where Verrica’s contract manufacturer produced bulk solution for VP-102; (2) that these deficiencies were not corrected when Verrica resubmitted its NDA for VP-12 for molluscum; (3) that the foregoing posed significant risks to Verrica obtaining regulatory approval for VP-102 for molluscum; and (4) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

Digital Turbine, Inc. (NASDAQ: APPS)
Course period: August 9, 2021 – May 17, 2022
Lead Applicant Deadline: August 5, 2022

The Complaint filed in this Class Action alleges that throughout the Class Period, the Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the business, operations and societal prospects. Specifically, the defendants failed to disclose to investors: (1) that the company’s recent acquisitions, AdColony and Fyber, act as agents in some of their respective product lines; (2) that, therefore, revenues from these product lines should be reported net of license fees and revenue sharing, rather than on a gross basis; (3) that the Company’s internal control over financial reporting relating to revenue recognition was deficient; and (4) that as a result of the foregoing, the Company’s net revenues were overstated throughout fiscal 2022; and (5) that as a result of the foregoing, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

Teladoc Health, Inc. (NYSE: TDOC)
Course period: October 28, 2021 – April 27, 2022
Lead Applicant Deadline: August 5, 2022

The Complaint filed in this Class Action alleges that throughout the Class Period, the Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts regarding the business, operations and societal prospects. Specifically, the defendants failed to disclose to investors that: (1) increased competition, among other factors, was negatively impacting BetterHelp and Teladoc’s chronic care businesses; (2) as a result, the growth of these companies was less sustainable than the defendants had led investors to believe; (3) as a result, Teladoc’s fiscal 2022 revenue and Adjusted EBITDA projections were unrealistic; (4) as a result of all of the foregoing, Teladoc would be required to recognize a significant non-cash goodwill impairment charge; and (5) therefore, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis at all relevant times.

To be a member of these class actions, you do not have to take any action at this time; you can retain the services of a lawyer of your choice or do nothing and remain an absentee member of the class action. If you would like to know more about these class action lawsuits, or if you have any questions regarding this announcement or your rights or interests in these matters, please contact Frank R. Cruz, The Law Offices of Frank R. Cruz , 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067 at 310-914-5007, by email at info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If requesting by email, please include your mailing address, phone number and number of shares purchased.

This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.

contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com